Hanson & Doremus Investment Management lifted its stake in shares of Welltower Inc (NYSE:WELL) by 50.0% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 1,500 shares of the real estate investment trust’s stock after buying an additional 500 shares during the quarter. Hanson & Doremus Investment Management’s holdings in Welltower were worth $122,000 at the end of the most recent reporting period.

Other large investors also recently modified their holdings of the company. BlackRock Inc. raised its position in Welltower by 3.7% in the 1st quarter. BlackRock Inc. now owns 39,917,986 shares of the real estate investment trust’s stock valued at $3,097,636,000 after purchasing an additional 1,414,802 shares during the last quarter. FMR LLC raised its position in Welltower by 4.1% in the 1st quarter. FMR LLC now owns 9,139,695 shares of the real estate investment trust’s stock valued at $709,239,000 after purchasing an additional 363,724 shares during the last quarter. Principal Financial Group Inc. raised its position in Welltower by 13.4% in the 1st quarter. Principal Financial Group Inc. now owns 8,719,318 shares of the real estate investment trust’s stock valued at $676,620,000 after purchasing an additional 1,032,562 shares during the last quarter. Daiwa Securities Group Inc. raised its position in Welltower by 6.6% in the 1st quarter. Daiwa Securities Group Inc. now owns 7,184,481 shares of the real estate investment trust’s stock valued at $557,516,000 after purchasing an additional 446,202 shares during the last quarter. Finally, Northern Trust Corp raised its position in Welltower by 2.6% in the 1st quarter. Northern Trust Corp now owns 6,380,133 shares of the real estate investment trust’s stock valued at $495,099,000 after purchasing an additional 162,050 shares during the last quarter. Institutional investors and hedge funds own 87.01% of the company’s stock.

WELL traded up $0.50 during trading on Friday, hitting $83.13. The stock had a trading volume of 1,588,763 shares, compared to its average volume of 1,784,639. The company has a quick ratio of 1.84, a current ratio of 1.84 and a debt-to-equity ratio of 0.79. The company has a market capitalization of $33.66 billion, a price-to-earnings ratio of 20.63, a P/E/G ratio of 4.09 and a beta of 0.29. The business has a 50-day moving average of $83.51. Welltower Inc has a twelve month low of $60.74 and a twelve month high of $86.91.

Welltower (NYSE:WELL) last announced its quarterly earnings data on Tuesday, April 30th. The real estate investment trust reported $1.02 earnings per share (EPS) for the quarter, meeting the consensus estimate of $1.02. The company had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.24 billion. Welltower had a net margin of 13.06% and a return on equity of 4.97%. Welltower’s revenue was up 16.0% compared to the same quarter last year. During the same period in the previous year, the company posted $0.99 EPS. As a group, analysts predict that Welltower Inc will post 4.19 earnings per share for the current year.

In other Welltower news, CEO Thomas J. Derosa sold 19,307 shares of the business’s stock in a transaction on Tuesday, May 14th. The shares were sold at an average price of $77.90, for a total value of $1,504,015.30. The sale was disclosed in a legal filing with the SEC, which is available through this link. Insiders own 0.15% of the company’s stock.

Several analysts recently commented on WELL shares. BMO Capital Markets reduced their price target on shares of AKITA Drilling from C$5.00 to C$3.50 in a research report on Tuesday, May 7th. Raymond James started coverage on shares of Adverum Biotechnologies in a research report on Thursday, June 13th. They issued a “market perform” rating for the company. Finally, Scotiabank set a $80.00 price target on shares of Welltower and gave the company a “hold” rating in a research report on Friday, June 14th. Seven analysts have rated the stock with a hold rating and ten have given a buy rating to the company. Welltower presently has a consensus rating of “Buy” and a consensus price target of $74.79.

About Welltower

Welltower Inc (NYSE:WELL), an S&P 500 company headquartered in Toledo, Ohio, is driving the transformation of health care infrastructure. The Company invests with leading seniors housing operators, post-acute providers and health systems to fund the real estate infrastructure needed to scale innovative care delivery models and improve people's wellness and overall health care experience.

Featured Story: Discount Rate

Institutional Ownership by Quarter for Welltower (NYSE:WELL)

Receive News & Ratings for Welltower Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Welltower and related companies with MarketBeat.com's FREE daily email newsletter.